about
Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study.A multi-country study of intussusception in children under 2 years of age in Latin America: analysis of prospective surveillance data.Antimicrobial and anti-inflammatory treatment of bacterial meningitis.Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trialEnhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis.Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents.Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age.Efavirenz Capsule Sprinkle and Liquid Formulations With Didanosine and Emtricitabine in HIV-1-infected Infants and Children 3 Months to 6 Years of Age: Study AI266-922.Pediatric osteomyelitis in Panama.Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients.Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management.Persistence of Meningococcal Antibodies and Response to a Third Dose After a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents.A randomized, open-label study of the safety and efficacy of switching stavudine or zidovudine to tenofovir disoproxil fumarate in HIV-1-infected children with virologic suppression.A consensus statement: meningococcal disease among infants, children and adolescents in Latin America.Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness.Correction: Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial.Pharmacokinetics and pharmacodynamics of gatifloxacin in children with recurrent otitis media: application of sparse sampling in clinical development.Starry, starry night.Induction of suppurative arthritis in rabbits by Haemophilus endotoxin, tumor necrosis factor-alpha, and interleukin-1 beta.Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.Gatifloxacin therapy for children: turn on the light.Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study.Factors influencing access of pregnant women and their infants to their local healthcare system: a prospective, multi-centre, observational study.Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials.Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country.Bacterial meningitis in childrenFour-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults.Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus GastroenteritisImpact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame[Persistence of dengue in the tropics]Specific detection of Haemophilus influenzae type b lipooligosaccharide by a polymyxin B monoclonal antibody assaySpiramycin for treatment of Cryptosporidium enteritisIncreased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapyBacterial contamination rates for non-clean-catch and clean-catch midstream urine collections in uncircumcised boysDexamethasone attenuation of cytokine-mediated articular cartilage degradation in experimental lapine Haemophilus arthritisBrain abscess in children
P50
Q29197289-07CBD777-C09D-4536-8DF5-AEAA8EDE357CQ30633803-ECB36411-5DE5-4E54-B211-A9BE39CE8835Q33724683-6E483ABD-E417-45FA-8376-217F52B81EA0Q33848675-C633E55E-520C-4C33-B6A7-C0A92D81494BQ34215339-837C0AD4-7A09-44B0-B997-8351CA563563Q35887131-0366B486-2690-4104-9033-A4281F62F9BCQ37115709-1955E19F-E7F9-4809-A169-4FAF787458DDQ40530203-550604D5-8B31-4A7A-B1D2-8D7F5E59CAF3Q40647719-F5D3A5E2-DB52-49C7-94CF-97B96CDE2D52Q40664092-B53609BA-CD2F-4F32-BA58-DEC3CF928AC4Q40760088-26E207B4-323D-4BF0-BE33-7B4DC4FE78D2Q40864473-552684F3-02B6-4183-AAC4-B2AA346A704AQ41127866-FA052B0E-16EF-4750-8F43-9AC17196063DQ41437971-0EB31657-5C1C-476D-AB9B-6B695CB9C324Q42231285-FE1396E3-8C1E-4B85-BCD3-FAC53B6900C4Q42248000-89365EDE-4899-4338-923E-7F3AB1A60881Q42396149-6B37E3C8-B263-44E3-8BB0-84F31DD4163BQ42631825-60315B85-F633-4D62-A9CE-3798D1C45E1EQ43989244-C081B2C4-B0FB-4C37-9827-7E4007072CE3Q44176085-2143005C-8D5D-4881-A86C-90A6B08F1126Q45604589-D614888A-7EAB-45C7-856B-7C73B47836A4Q46803986-64FC64B5-CF00-4468-BED9-C2DCC55DA4C6Q46977024-DBC2D28C-C1E9-42D9-AD05-F82E04010B16Q47198460-06CF1FBD-972D-45E8-8339-07126FB17A60Q47584703-D496DF32-1A7E-4E2E-9F66-FFC57DC3FC28Q47656751-9EDF42F3-8826-434D-91E3-09AF6FABD5A7Q52687609-75546375-3AE3-4841-A9BC-A635D0CFE2AEQ53873752-A4FF0E2D-AACE-4CA8-84D6-46AE972EDD0AQ54056574-2A96C532-DB6D-4912-929E-0BC5BFD1EB48Q54075969-896AA2FE-4FC0-41D3-B0F5-B426D2BDD641Q55021359-1939532C-9278-4BF0-B1A4-801133E58F64Q56995254-CD14CA4A-65A9-4088-987D-55322C8254D9Q58094225-77B638B9-6C4B-40BF-AA64-F9E344B0084DQ64903260-42C353D7-9DE8-488C-B035-CB34F3F44CAEQ69357207-E02B6D08-644E-448D-AC72-5D21DFF92454Q69522733-540A6B99-26F5-44AC-82F3-AC1BDFF7FC67Q69787773-FFC35327-BD51-4B8B-BCAB-3FA3DAA1646FQ69934847-4AE0E239-422C-4028-B660-1011C2EA7DE7Q72656419-3DBD7535-1719-4442-AC13-020D25937D86Q73709820-239E774D-DD79-4B60-B37C-E1F3139DC32E
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Sáez-Llorens X
@ast
Sáez-Llorens X
@es
Sáez-Llorens X
@nl
Xavier Sáez-Llorens
@en
type
label
Sáez-Llorens X
@ast
Sáez-Llorens X
@es
Sáez-Llorens X
@nl
Xavier Sáez-Llorens
@en
prefLabel
Sáez-Llorens X
@ast
Sáez-Llorens X
@es
Sáez-Llorens X
@nl
Xavier Sáez-Llorens
@en
P31
P496
0000-0002-1149-5905